A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
Clinical trial NCT04978493 · TERMINATED
Trial details
- NCT number
- NCT04978493
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2024-07-08
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.